SCHEMBL29366332

SCHEMBL29366332

O=P1(O)Oc2ccc3ccccc3c2-c2c(ccc3ccccc23)O1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 18/20 1.00
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
KDM4E B2RXH2 2/20 0.53
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29726541 1.00 GPR84 (1.00) GPR84MEN1KMT2AKDM4ERECQL
SCHEMBL296014 1.00 GPR84 (1.00) GPR84MEN1KMT2AKDM4ERECQL
Alcohol SCHEMBL15876328 0.92 GPR84 (0.84) GPR84MEN1KMT2AKDM4ERECQL
Pyridine SCHEMBL31748578 0.89 GPR84 (0.79) GPR84MEN1KMT2AKDM4ERECQL
SCHEMBL18965878 0.87 GPR84 (0.75) GPR84MEN1KMT2AKDM4ERECQL
SCHEMBL21615657 0.84 GPR84 (0.82) GPR84MEN1KMT2AKDM4ERECQL
SCHEMBL15198302 0.83 GPR84 (0.69) GPR84MEN1KMT2AKDM4ERECQL
SCHEMBL31280085 0.81 GPR84 (0.69) GPR84MEN1KMT2AKDM4E
SCHEMBL3967442 0.81 GPR84 (0.69) GPR84MEN1KMT2AKDM4E
SCHEMBL887345 0.81 GPR84 (0.69) GPR84MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4431549-B1 METHOD FOR PREPARING COMB POLYMER AND USE THEREOF FOR FORMING SOLID ELECTROLYTE COMMISSARIAT ENERGIE ATOMIQUE (FR) 2025-06-25 EP claimed
EP-4431548-B1 METHOD FOR PREPARING COMB POLYMER AND USE THEREOF FOR FORMING SOLID ELECTROLYTE COMMISSARIAT ENERGIE ATOMIQUE (FR) 2025-06-25 EP claimed
EP-4431549-A1 METHOD FOR PREPARING COMB POLYMER AND USE THEREOF FOR FORMING SOLID ELECTROLYTE Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2024-09-18 EP claimed
EP-4431548-A1 METHOD FOR PREPARING COMB POLYMER AND USE THEREOF FOR FORMING SOLID ELECTROLYTE Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2024-09-18 EP claimed
WO-2024130425-A1 METHODS OF MAKING 2-AMINO-L-(3-HYDROXY-2,6-DIMETHYLPHENYL)-5,6- DIMETHYL-LH-PYRROLO-[2,3-B]PYRIDINE-3-CARBOXAMIDE, A MYTL INHIBITOR REPARE THERAPEUTICS INC. (CA) 2024-06-27 WO claimed
CN-111051276-B Method for producing isocyanates 科思创德国股份有限公司 2022-09-09 CN claimed
US-20220242840-A1 PROCESS FOR SYNTHESIZING 5-HYDROXYMETHYLFURFURAL IFP Energies Nouvelles (FR) 2022-08-04 US claimed
CN-108718527-B Process for preparing compounds 豪夫迈·罗氏有限公司 2022-06-28 CN claimed
EP-3980419-A1 ALTERNATIVE PROCESS FOR THE PREPARATION OF 4-PHENYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDIN-6-YL]METHYL]-3-OXO-5,6,8,8A-TETRAHYDRO-1H-IMIDAZO[1,5-A]PYRAZIN-2-YL]-CARBOXYLIC ACID F. Hoffmann-La Roche AG (CH) 2022-04-13 EP claimed
CN-113993855-A Method for synthesizing 5-hydroxymethylfurfural IFP 新能源公司 2022-01-28 CN claimed
CN-122094945-A Production of 5-HMF in nonaqueous solvents using concentration of 5-HMF prior to liquid-liquid extraction 2026-05-26 CN disclosed
US-20260132108-A1 PREPARATION OF MESEMBRINE KANNA HEALTH LTD (GB) 2026-05-14 US disclosed
EP-4598904-A1 PREPARATION OF MESEMBRINE Kanna Health Limited (GB) 2025-08-13 EP disclosed
EP-4431548-B1 METHOD FOR PREPARING COMB POLYMER AND USE THEREOF FOR FORMING SOLID ELECTROLYTE COMMISSARIAT ENERGIE ATOMIQUE (FR) 2025-06-25 EP disclosed
EP-4431549-B1 METHOD FOR PREPARING COMB POLYMER AND USE THEREOF FOR FORMING SOLID ELECTROLYTE COMMISSARIAT ENERGIE ATOMIQUE (FR) 2025-06-25 EP disclosed
EP-3986881-A1 PROCESS FOR SYNTHESIZING 5-HYDROXYMETHYLFURFURAL IFP Energies nouvelles (FR) 2022-04-27 EP disclosed
EP-3980419-A1 ALTERNATIVE PROCESS FOR THE PREPARATION OF 4-PHENYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDIN-6-YL]METHYL]-3-OXO-5,6,8,8A-TETRAHYDRO-1H-IMIDAZO[1,5-A]PYRAZIN-2-YL]-CARBOXYLIC ACID F. Hoffmann-La Roche AG (CH) 2022-04-13 EP disclosed
WO-2022053010-A1 FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2022-03-17 WO disclosed
CN-114085185-A Process for preparing bedaquiline and pharmaceutically acceptable salts thereof 东亚ST 株式会社 2022-02-25 CN disclosed
CN-113993855-A Method for synthesizing 5-hydroxymethylfurfural IFP 新能源公司 2022-01-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132108-A1 PREPARATION OF MESEMBRINE BHMT, TMSB10, MSMO1 GPR84 4287/4885MEN1 559/4885KMT2A 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.